2904, 2021
Helping the Medicine go Down
In this article, Dr Simon Bryson, CEO and Co-Founder of [...]
2311, 2021
TRUST CONSULTANT PRESENTED WITH PRESTIGIOUS AWARD
Dr Tony Tham Consultant Physician and Gastroenterologist in the Ulster [...]
1611, 2021
Queen’s University Belfast Leading £1.2m Project to Revolutionise Medical Treatment
Queen’s University Belfast are leading a £1.2m project to improve [...]
911, 2021
Consultant Neurologist James I Morrow Returns with a Carefully Crafted Medical Thriller set in Dublin
Sometimes one does get what one wishes for, and then [...]
-
Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM) GalleryLupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)
411, 2021
Lupin’s Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders (NDM)
Slough, UK, 4 November 2021: Global pharma major Lupin today announces [...]
211, 2021
Register for the first #LivingDiabetesTogether webinar!
Living Diabetes together – Starting insulin Tuesday, November 9th, 2021 [...]
211, 2021
J&J Webinar Invitation: Children’s Healthcare: Overview & Guidance for Recommendation
Discover how to offer better support and guidance on children’s [...]
